3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Breast
1
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
1
Lymphoma
1
Health Education
1
Breast Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
fludarabine
3
aldesleukin
3
Cyclophosphamide
3
vedolizumab
2
atezolizumab
2
Riluzole
2
LDP-02
2
Infliximab
2
Immunoglobulin G
2
Fecal Microbiota Transplantation
2
Disulfides
2
CT-P13
2
prednylidene
1
pembrolizumab
1
motexafin gadolinium
1
deltacortene
1
Tinzaparin
1
Therapeutics
1
Taste
1
Standard of Care
1
Radiotherapy
1
Prednisone
1
Practice Guidelines as Topic
1
Loperamide
1
Interleukin-2
1
Immunotherapy
1
Geriatric Assessment
1
Fatty Acids, Omega-3
1
Exercise
1
Endoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Geriatric Assessment
×
Thoracic
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled